-
Class-Action Lawsuit Filed Against Remdesivir Manufacturer Over Alleged Deceptive Practices -
Gilead Widens Battle Against Alleged Counterfeit HIV Drug Ring
-
Rand Paul Discloses His Wife’s Investment in Company Behind Remdesivir, 16 Months Later
-
Remdesivir Therapy Has ‘Little Effect’ on COVID-19 Mortality: WHO Study
-
Gilead to Deliver More Remdesivir to Europe From Autumn
-
Gilead to Charge Hundreds Per Vial for Remdesivir
-
Gilead Drug Has Small Benefit Against Moderate COVID-19, New Trial Shows
-
Remdesivir Speeds COVID-19 Recovery but Needs Supplement, Researchers Find
-
Gilead ‘Aware’ of Positive Data From Study of Remdesivir’s Effects Against COVID-19
-
Remdesivir Study Ended Early With No Improvement for COVID-19 Patients
-
Coronavirus Treatments Could Be Ready in Months: Executives
-
Gilead to Start Its Own Studies of Potential Coronavirus Treatment
-
US Starts Clinical Trial of Remdesivir as Possible Coronavirus Treatment
